Brownstone Institute
Covid was Spreading Across the U.S. in 2019

BY
If it could be proven that the virus that causes COVID-19 was spreading throughout the world by November 2019 (or even earlier), the shift in the Covid narrative might be seismic.
For example, if the virus had already infected large numbers of people, the justification for the lockdowns of mid-March 2020 to “slow or stop the spread” of a newly arrived virus would be shown to be nonsense.
Estimates of the number of people who had already developed natural immunity as well as of the infection fatality rate (IFR) might be dramatically different. It would suggest the disease was not nearly as lethal as experts proclaimed. The mass fear in the public – a prerequisite for lockdowns and later for mass vaccinations – might be much lower.
Given these points, it’s odd public health officials and investigative journalists have eschewed serious investigations that might confirm this virus had already spread around the world before January 1st, 2020.
A common-sense project to ‘prove’ early spread was occurring would be simply to test tranches of blood that were donated before the birth date of the official outbreak (December 31st 2019).
Surprisingly, however, very few antibody studies of archived blood collected before December 31st 2019 have occurred. Will Jones of The Daily Skeptic recently highlighted one such study published by researchers in France as well as a sewage study from Brazil. The first provides antibody evidence and the second RNA evidence the novel coronavirus was spreading by November 2019 in these countries.
To Will’s list, I’d add the only antibody study of archived Red Cross blood conducted by the US CDC to date. This study found 39 antibody-positive serum samples collected December 13th-16th, 2019 in California, Washington and Oregon (2% of blood samples collected from these states tested positive for antibodies).
As it takes the human body one to two weeks to produce detectable levels of antibodies, most of these 39 antibody-positive donors had been infected in November 2019 if not earlier.
For some reason, American officials performed only one antibody study of blood collected by blood bank organizations. It’s also strange that results of this study were not published until November 30th, 2020 – more than 11 months after the first tranche of archived Red Cross blood had been collected.
In a CDC press briefing held May 29th, 2020, CDC officials stated they’d searched for and could find no evidence the novel coronavirus had been “introduced” anywhere in America prior to January 20th, 2020.
I believe this statement was false, as by the time this press briefing was held, copious evidence of early spread had already been disseminated via published news accounts. For example, I’ve identified at least 17 Americans who were sick with definite Covid symptoms in November and December 2019 and all 17 had antibody evidence of prior infection. Also, all 17 of these reports were published by prominent news organizations at least 13 days before this press conference.
While a source of important evidence, antibody studies are not necessary to prove that early spread almost certainly occurred in America. Close examination of individual case histories also allows one confidently to reach this conclusion. What follows is a summary of three individual histories that lead me to conclude community spread was already occurring in America by November 2019 and probably October 2019.
For details on other American cases that date to December 2019, see this Seattle Times story and a feature story I wrote that, for some reason, was completely ignored by the mainstream press and public health officials, a fact I document in this follow-up article.
Case 1: Michael Melham of Belleville, NJ
Michael Melham, the Mayor of Belleville, NJ, was among a large group of New Jersey municipal employees who attended a conference in Atlantic City on November 19th-21st 2019. While at the conference, Melham experienced symptoms common to COVID-19.
“I was definitely feeling sick when I was there, and fought my way through it,” Mayor Melham told NJ Advance Media on April 30th, 2020.
“I have never been sicker in my entire life,” the Mayor said. “These symptoms included a 102-degree fever, chills, hallucinations and a sore throat that lasted for three weeks.” In a story published by Fox News, Mayor Melham said the illness made him feel “like a heroin addict going through withdrawals… I didn’t know what was happening to me. I never felt that I could be so sick.“
Mayor Melham felt sick enough to contact his doctor who diagnosed him with the flu. However, this diagnosis was given “over the phone” and Melham never actually received a flu test.
In late April 2020, Melham visited his doctor for his annual physical and brought up his November illness. The doctor administered an antibody test, which came back positive for Covid antibodies.
Melham later told me he actually received two positive antibody tests (previous reports mentioned just one).
“My first antibody test was a rapid test. My second was a blood test that was sent to a lab. Both were positive for the longer antibody,” Mayor Melham wrote in one email.
Mayor Melham has repeatedly made the important (if ignored) point that he tested positive for the ‘long’ (IgG) antibody. He tested negative for the IgM antibody. The presence of IgM antibodies indicate more recent infection and, per studies, these antibodies fade and are only detectable for about a month after infection.
This combination of antibody results would seem to rule out the possibility Mayor Melham experienced an asymptomatic case of Covid in the month before receiving his first antibody test. The only time Melham was sick was November 2020.
He added: “I will also tell you that since the media attention surrounding my claim, many others have come forward. I have emails from those who were actually at the same conference in Atlantic City NJ, who became just as sick as I was.”
Those who wish to gauge the credibility of the Mayor’s claims can view this four-minute YouTube interview with Mayor Melham.
I also asked Mayor Melham a question no other journalist seems to have asked him. “Did any public health official ever contact you to investigate your possible case?”
Melham’s email response: “No, nothing.”
DISCUSSION
Multiple acquaintances as well as his physician would confirm Melham was sick with symptoms common to Covid victims in November. Since he received two positive antibody tests, if the results were a false positive, he received two false positives.
As noted, Mayor Melham reports receiving emails from “multiple people… who were at the same conference who became just as sick as I was”. This would suggest the presence of community spread – a possibility which might have been confirmed if contact tracers had tested the people who’d been sick at the same conference for antibodies.
We know no public health officials contacted Mayor Melham to investigate his claim. We also know, thanks to nj.com‘s reporting, that state health officials were aware of his claim:
“Asked about the Mayor’s statements, the state health department declined comment. A spokesperson for Gov. Phil Murphy did not immediately respond to a message.”
The following points should also be emphasized. If his diagnosis had been confirmed by public health officials, Mayor Melham would have been the first known Covid case in the world, and would have been the first confirmed case in America by approximately 61 days (the first official case in America is still recorded as January 20th, 2020 – a man from Washington state who had recently returned from Wuhan).
Significantly, Mayor Melham can date the onset of his symptoms. Per numerous studies, it takes two to 14 days after infection for symptoms to manifest. This means Mayor Melham would have been infected some time between November 5th and November 19th, 2019.
Since Mayor Melham did not give the virus to himself, logic tells us the chain of transmission that ended with Michael Melham being symptomatic around November 20th, 2019 very possibly began before November 1st, 2019. This would mean that community spread was possibly occurring in New Jersey as early as October 2019.
Case 2: Uf Tukel of Delray Beach, Florida
As reported by the Palm Beach Post on May 16th, 2020:
“At least 11 people… on two small blocks alone… in a small Delray Beach (Florida) neighborhood tested positive for coronavirus antibodies in April. They felt symptoms as early as November (2019). “It didn’t have a name back then, but I have no doubt now that it was the coronavirus,” one neighbor said.”
The article names seven of these individuals and provides details and quotes about their symptoms. These seven people include Uf Tukel who was “first among (residents of the neighborhood) to feel sick in late November (2019)… For weeks, he had body aches, a severe cough and night sweats.”
While “Tukel is reluctant to say he had the coronavirus a month before Chinese officials reported the outbreak to the World Health Organisation, ‘I had all the symptoms though,’ Tukel said.”
The same logic applied to Michael Melham’s possible case would apply to Mr. Tukel’s possible case. That is, the unknown person who infected Mr. Tukel was infected earlier than Tukel, and the unknown person who infected this person contracted the virus even earlier, suggesting early spread was also happening by some point in November, if not October, in Delray Beach, Florida.
If confirmed, Mr. Tukel’s case would indicate that American cases in November were not isolated to the state of New Jersey.
Several other points included in the Post’s coverage deserve attention.
These possible Delray Beach cases include two couples, with one spouse presumably infecting the other. One child of one of these couples became infected, providing further evidence of community spread.
According to the story, none of the individuals experienced close contacts with other non-family residents of the same neighborhood. That is, there seems to be no evidence of neighbor-to-neighbor transmission.
According to the story, “all (11 individuals) recovered and haven’t been sick since.” None of the 11 had travelled to China.
Like Michael Melham, none of these 11 people tested positive for the ‘short’ (IgM) antibodies – thus none had been recently infected.
The Post article also includes this eye-opening information: “Since March (2020) about two-fifths (approximately 200, 40%) of the 500 antibody tests taken by Xera Med (a DelRay Beach private testing lab/medical clinic) have been positive, said CEO Emily Rentz.” The first two confirmed cases in Florida were recorded March 1st.
The following sentence from this article might be even more significant: “The lab shares its data on positive tests with the state health department, (Rentz) added.”
And from the same article: “The state wouldn’t say whether it is collecting antibody data from hospitals or private laboratories.”
The Post article referenced a May 5th article by the same newspaper:
“In Florida, health department reports show patients who eventually tested positive for the virus experienced symptoms as early as January. The Florida Department of Health hasn’t explained those potential fault lines in the state’s assertion that the first cases didn’t appear in Florida until March.”
The fact 40% of 500 antibody tests administered by the clinic between March and early May 2020 tested positive for Covid antibodies suggests infections were widespread in this community. And according to the CEO of this lab, these antibody results were being shared with Florida State Department of Health officials.
And apparently these weren’t the only positive antibody results that were being reported by testing labs. As reported in the same article:
The University of Miami, in randomly testing Miami-Dade County residents for antibodies, has found that the rate of infection could be 16 times higher than state data suggests, said Dr. Erin Kobetz, a professor and lead researcher on the project …
“Since first publishing her findings, Kobetz has heard from several people who shared experiences similar to the Tropic Isle neighbors… They described being sick in December and later testing positive for antibodies. They asked if what they’d experienced was COVID-19.”
Significantly, if we count possible December 2019 cases, Americans from five geographically-dispersed US states were featured in published articles. An unknown number of Americans who’ve never been featured in a newspaper article undoubtedly fit the same profile. If one adds this unknown number of never-identified people to the list of known individuals, evidence the novel coronavirus was spreading widely across America in November and December 2019 becomes even more compelling.
Not every infectious disease expert agrees with the CDC’s assessment that widespread transmission did not begin until January 20th, 2020.
“It’s possible that the disease spread as early as November,” Dr. Kobetz said.
As in New Jersey, apparently no official with the Florida Department of Health contacted any of the 11 people referenced in the Post’s article. Nor have public health officials apparently followed up with Emily Renz, CEO of Xera Med, who stated approximately 200 other local residents received positive Covid antibody tests at the clinic between March and the end of April.
Ms. Renz noted that information on all of these positive test results had been forwarded to officials at the state’s health agency. Which prompts this question: How many clinics and testing labs in America also forwarded positive antibody test results to state health agencies, agencies which presumably could and would pass this information along to their colleagues at the CDC or NIH?
What the public doesn’t know but should is how many other Americans – those with lab results not reported in the press – also tested positive for antibodies between March and early May 2020. Presumably, the CDC and state and local health agencies have these data, which have never been released to the public.
Indeed, I’ve come to believe it’s possible at least some high-ranking officials may have conspired to suppress antibody results which, if published, might have led the public to conclude this virus was spreading widely months before officials said it had been introduced in this country. Such knowledge might have changed the way tens of millions of Americans evaluated their personal Covid risk as well as their support for lockdowns.
Case 3: Shane from Marin County, California
Perhaps the first early case in America (with antibody evidence that would confirm infection) is Shane of Marin County, California. Shane’s possible early case was not featured in a newspaper article, but by Shane himself in the reader comments section that followed a May 7th 2020 New York Times story (the story describes symptoms experienced by Covid patients).
Writes Shane: “I had COVID-19 last fall, far earlier than anyone else I’ve heard of. I suspect I caught it while on an overseas trip to Italy and the Middle East – I’ve taken two antibody tests in the past month, both of which confirmed I was infected.”
As Shane recounts, he was extremely sick with signature Covid symptoms.
“For me the worst symptom by far was the dry, unproductive cough. The cough was so intense, so relentless, it left me with bruised ribs and a horrible searing pain in my chest, which also felt as if someone were sitting on it. The fever at one point reached 104.9 upon which I began hallucinating – seeing my dogs talking to me and forgetting how to open a sliding glass door. Horrible chills which led to my teeth chattering so hard my jaw ached were also another noxious gift of Covid.
“What I most remember about my experience with Covid is pain, pain from coughing, pain in my body and head, pain everywhere around me, like a smothering red blanket. At times I felt I was going to die during that week and even today I must admit I am surprised I didn’t.”
Adding credibility to his claim, Shane’s post cited two labs where he claims to have received his positive antibody tests.
“The local health centre in West Marin is where I took the latest one. The other one I took directly at the manufacturer’s location – ARCpoint Labs in Richmond. That one is only 87% accurate and not FDA approved so that’s why I took the more recent one, which was done through Quest Labs I believe.”
In the comment thread, one poster suggests it’s unlikely Shane developed Covid as there had been no reported confirmed cases from that time. This poster opines that Shane was sick with some other nasty virus and later developed an asymptomatic case of Covid. However, Shane stuck to his theory and presented reasons for his opinion.
“I suppose it’s possible but I tend to think that since what I contracted had the exact same symptoms as COVID-19 – that COVID-19 is what I had. In addition, mid-February through mid-March I was in isolation, caring for my sister who died mid-March from metastatic cervical cancer. When COVID-19 made its first appearance in the U.S. in February we very quickly put in strict isolation protocols as my sister had a compromised immune system due to chemotherapy, further insulating myself from contact and infection as well.”
Shane does not report what month he thinks he had Covid – only that it was “last fall… and far earlier than anyone else I’ve heard.” He could have been sick in November or October (maybe even late September). Shane (if he really had Covid) contracted the virus from an unknown person who would have been infected earlier than him.
Shane shared his belief he might have contracted the virus in Italy or in the Middle East, which, if true, would provide more evidence of early global spread. However, it’s also possible he contracted the virus in California.
Shane’s claim was posted in the moderated New York Times’ comments section, meaning one or more Times employees were aware of Shane’s startling claim. I imagine any Covid article, including the popular reader comments, published by the New York Times was also read by at least some employees of the CDC, NIH etc.
As only paid subscribers can make comments in the New York Times comment section, the newspaper possesses Shane’s subscription information. That is, someone at the newspaper could have easily ascertained Shane’s full name and contact information, including his street and email address.
For what it’s worth, I contacted the NY Times via its news tip email address and suggested a reporter follow up on Shane’s eye-opening claim. I did not receive a reply. This leads me to believe the New York Times is not interested in pursuing evidence of early spread in America, even in the case of a person who very well could be the first known Covid case in the world.
Conclusion
At least three Americans (either known, or in Shane’s case, easily identifiable if effort was made) possessed antibody evidence of Covid in November 2019. The infection chain that ultimately produced these symptomatic individuals likely traces to October 2019. Of note, two of these individuals received two positive antibody tests, making a false positive explanation far less likely. These cases occurred not in one state, but three states (New Jersey, Florida and California). Americans from at least 12 US states had antibody evidence of infection prior to mid-January 2020.
As far as I know, none of these 123 Americans (17 Americans identified in press reports and 106 in the Red Cross antibody study) had travelled to China. All 123 are either known or could be identified. (For unstated reasons, the CDC did not interview any of the 106 Americans who provided positive blood samples to the Red Cross.) The figure 123 does not include the unknown individuals who infected these Americans, nor does it include the possible cases that never became known to reporters or the public.
This antibody evidence strongly suggests the novel coronavirus was being transmitted person-to-person throughout the United States well before January 1st, 2020, and was probably occurring by October 2019.
If certain officials concealed this truth or were simply too incompetent to figure it out, any trust placed in such authorities is undermined. The above information also suggests that officials are not interested in conducting serious investigations into early spread of the virus, prompting a skeptic to wonder why this might be the case.
My hope is that journalists with more resources than myself, as well as officials and scientists, will belatedly and seriously investigate the strangely-ignored evidence of early spread.
This story also appeared in The Daily Skeptic.
Brownstone Institute
FDA Exposed: Hundreds of Drugs Approved without Proof They Work

From the Brownstone Institute
By
The US Food and Drug Administration (FDA) has approved hundreds of drugs without proof that they work—and in some cases, despite evidence that they cause harm.
That’s the finding of a blistering two-year investigation by medical journalists Jeanne Lenzer and Shannon Brownlee, published by The Lever.
Reviewing more than 400 drug approvals between 2013 and 2022, the authors found the agency repeatedly ignored its own scientific standards.
One expert put it bluntly—the FDA’s threshold for evidence “can’t go any lower because it’s already in the dirt.”
A System Built on Weak Evidence
The findings were damning—73% of drugs approved by the FDA during the study period failed to meet all four basic criteria for demonstrating “substantial evidence” of effectiveness.
Those four criteria—presence of a control group, replication in two well-conducted trials, blinding of participants and investigators, and the use of clinical endpoints like symptom relief or extended survival—are supposed to be the bedrock of drug evaluation.
Yet only 28% of drugs met all four criteria—40 drugs met none.
These aren’t obscure technicalities—they are the most basic safeguards to protect patients from ineffective or dangerous treatments.
But under political and industry pressure, the FDA has increasingly abandoned them in favour of speed and so-called “regulatory flexibility.”
Since the early 1990s, the agency has relied heavily on expedited pathways that fast-track drugs to market.
In theory, this balances urgency with scientific rigour. In practice, it has flipped the process. Companies can now get drugs approved before proving that they work, with the promise of follow-up trials later.
But, as Lenzer and Brownlee revealed, “Nearly half of the required follow-up studies are never completed—and those that are often fail to show the drugs work, even while they remain on the market.”
“This represents a seismic shift in FDA regulation that has been quietly accomplished with virtually no awareness by doctors or the public,” they added.
More than half the approvals examined relied on preliminary data—not solid evidence that patients lived longer, felt better, or functioned more effectively.
And even when follow-up studies are conducted, many rely on the same flawed surrogate measures rather than hard clinical outcomes.
The result: a regulatory system where the FDA no longer acts as a gatekeeper—but as a passive observer.
Cancer Drugs: High Stakes, Low Standards
Nowhere is this failure more visible than in oncology.
Only 3 out of 123 cancer drugs approved between 2013 and 2022 met all four of the FDA’s basic scientific standards.
Most—81%—were approved based on surrogate endpoints like tumour shrinkage, without any evidence that they improved survival or quality of life.
Take Copiktra, for example—a drug approved in 2018 for blood cancers. The FDA gave it the green light based on improved “progression-free survival,” a measure of how long a tumour stays stable.
But a review of post-marketing data showed that patients taking Copiktra died 11 months earlier than those on a comparator drug.
It took six years after those studies showed the drug reduced patients’ survival for the FDA to warn the public that Copiktra should not be used as a first- or second-line treatment for certain types of leukaemia and lymphoma, citing “an increased risk of treatment-related mortality.”
Elmiron: Ineffective, Dangerous—And Still on the Market
Another striking case is Elmiron, approved in 1996 for interstitial cystitis—a painful bladder condition.
The FDA authorized it based on “close to zero data,” on the condition that the company conduct a follow-up study to determine whether it actually worked.
That study wasn’t completed for 18 years—and when it was, it showed Elmiron was no better than placebo.
In the meantime, hundreds of patients suffered vision loss or blindness. Others were hospitalized with colitis. Some died.
Yet Elmiron is still on the market today. Doctors continue to prescribe it.
“Hundreds of thousands of patients have been exposed to the drug, and the American Urological Association lists it as the only FDA-approved medication for interstitial cystitis,” Lenzer and Brownlee reported.
“Dangling Approvals” and Regulatory Paralysis
The FDA even has a term—”dangling approvals”—for drugs that remain on the market despite failed or missing follow-up trials.
One notorious case is Avastin, approved in 2008 for metastatic breast cancer.
It was fast-tracked, again, based on ‘progression-free survival.’ But after five clinical trials showed no improvement in overall survival—and raised serious safety concerns—the FDA moved to revoke its approval for metastatic breast cancer.
The backlash was intense.
Drug companies and patient advocacy groups launched a campaign to keep Avastin on the market. FDA staff received violent threats. Police were posted outside the agency’s building.
The fallout was so severe that for more than two decades afterwards, the FDA did not initiate another involuntary drug withdrawal in the face of industry opposition.
Billions Wasted, Thousands Harmed
Between 2018 and 2021, US taxpayers—through Medicare and Medicaid—paid $18 billion for drugs approved under the condition that follow-up studies would be conducted. Many never were.
The cost in lives is even higher.
A 2015 study found that 86% of cancer drugs approved between 2008 and 2012 based on surrogate outcomes showed no evidence that they helped patients live longer.
An estimated 128,000 Americans die each year from the effects of properly prescribed medications—excluding opioid overdoses. That’s more than all deaths from illegal drugs combined.
A 2024 analysis by Danish physician Peter Gøtzsche found that adverse effects from prescription medicines now rank among the top three causes of death globally.
Doctors Misled by the Drug Labels
Despite the scale of the problem, most patients—and most doctors—have no idea.
A 2016 survey published in JAMA asked practising physicians a simple question—what does FDA approval actually mean?
Only 6% got it right.
The rest assumed that it meant the drug had shown clear, clinically meaningful benefits—such as helping patients live longer or feel better—and that the data was statistically sound.
But the FDA requires none of that.
Drugs can be approved based on a single small study, a surrogate endpoint, or marginal statistical findings. Labels are often based on limited data, yet many doctors take them at face value.
Harvard researcher Aaron Kesselheim, who led the survey, said the results were “disappointing, but not entirely surprising,” noting that few doctors are taught about how the FDA’s regulatory process actually works.
Instead, physicians often rely on labels, marketing, or assumptions—believing that if the FDA has authorized a drug, it must be both safe and effective.
But as The Lever investigation shows, that is not a safe assumption.
And without that knowledge, even well-meaning physicians may prescribe drugs that do little good—and cause real harm.
Who Is the FDA Working for?
In interviews with more than 100 experts, patients, and former regulators, Lenzer and Brownlee found widespread concern that the FDA has lost its way.
Many pointed to the agency’s dependence on industry money. A BMJ investigation in 2022 found that user fees now fund two-thirds of the FDA’s drug review budget—raising serious questions about independence.

Yale physician and regulatory expert Reshma Ramachandran said the system is in urgent need of reform.
“We need an agency that’s independent from the industry it regulates and that uses high-quality science to assess the safety and efficacy of new drugs,” she told The Lever. “Without that, we might as well go back to the days of snake oil and patent medicines.”
For now, patients remain unwitting participants in a vast, unspoken experiment—taking drugs that may never have been properly tested, trusting a regulator that too often fails to protect them.
And as Lenzer and Brownlee conclude, that trust is increasingly misplaced.
- Investigative report by Jeanne Lenzer and Shannon Brownlee at The Lever [link]
- Searchable public drug approval database [link]
- See my talk: Failure of Drug Regulation: Declining standards and institutional corruption
Republished from the author’s Substack
Brownstone Institute
Anthony Fauci Gets Demolished by White House in New Covid Update

From the Brownstone Institute
By
Anthony Fauci must be furious.
He spent years proudly being the public face of the country’s response to the Covid-19 pandemic. He did, however, flip-flop on almost every major issue, seamlessly managing to shift his guidance based on current political whims and an enormous desire to coerce behavior.
Nowhere was this more obvious than his dictates on masks. If you recall, in February 2020, Fauci infamously stated on 60 Minutes that masks didn’t work. That they didn’t provide the protection people thought they did, there were gaps in the fit, and wearing masks could actually make things worse by encouraging wearers to touch their face.
Just a few months later, he did a 180, then backtracked by making up a post-hoc justification for his initial remarks. Laughably, Fauci said that he recommended against masks to protect supply for healthcare workers, as if hospitals would ever buy cloth masks on Amazon like the general public.
Later in interviews, he guaranteed that cities or states that listened to his advice would fare better than those that didn’t. Masks would limit Covid transmission so effectively, he believed, that it would be immediately obvious which states had mandates and which didn’t. It was obvious, but not in the way he expected.

And now, finally, after years of being proven wrong, the White House has officially and thoroughly rebuked Fauci in every conceivable way.
White House Covid Page Points Out Fauci’s Duplicitous Guidance
A new White House official page points out, in detail, exactly where Fauci and the public health expert class went wrong on Covid.
It starts by laying out the case for the lab-leak origin of the coronavirus, with explanations of how Fauci and his partners misled the public by obscuring information and evidence. How they used the “FOIA lady” to hide emails, used private communications to avoid scrutiny, and downplayed the conduct of EcoHealth Alliance because they helped fund it.
They roast the World Health Organization for caving to China and attempting to broaden its powers in the aftermath of “abject failure.”
“The WHO’s response to the COVID-19 pandemic was an abject failure because it caved to pressure from the Chinese Communist Party and placed China’s political interests ahead of its international duties. Further, the WHO’s newest effort to solve the problems exacerbated by the COVID-19 pandemic — via a “Pandemic Treaty” — may harm the United States,” the site reads.
Social distancing is criticized, correctly pointing out that Fauci testified that there was no scientific data or evidence to support their specific recommendations.
“The ‘6 feet apart’ social distancing recommendation — which shut down schools and small business across the country — was arbitrary and not based on science. During closed door testimony, Dr. Fauci testified that the guidance ‘sort of just appeared.’”
There’s another section demolishing the extended lockdowns that came into effect in blue states like California, Illinois, and New York. Even the initial lockdown, the “15 Days to Slow the Spread,” was a poorly reasoned policy that had no chance of working; extended closures were immensely harmful with no demonstrable benefit.
“Prolonged lockdowns caused immeasurable harm to not only the American economy, but also to the mental and physical health of Americans, with a particularly negative effect on younger citizens. Rather than prioritizing the protection of the most vulnerable populations, federal and state government policies forced millions of Americans to forgo crucial elements of a healthy and financially sound life,” it says.
Then there’s the good stuff: mask mandates. While there’s plenty more detail that could be added, it’s immensely rewarding to see, finally, the truth on an official White House website. Masks don’t work. There’s no evidence supporting mandates, and public health, especially Fauci, flip-flopped without supporting data.
“There was no conclusive evidence that masks effectively protected Americans from COVID-19. Public health officials flipped-flopped on the efficacy of masks without providing Americans scientific data — causing a massive uptick in public distrust.”
This is inarguably true. There were no new studies or data justifying the flip-flop, just wishful thinking and guessing based on results in Asia. It was an inexcusable, world-changing policy that had no basis in evidence, but was treated as equivalent to gospel truth by a willing media and left-wing politicians.
Over time, the CDC and Fauci relied on ridiculous “studies” that were quickly debunked, anecdotes, and ever-shifting goal posts. Wear one cloth mask turned to wear a surgical mask. That turned into “wear two masks,” then wear an N95, then wear two N95s.
All the while ignoring that jurisdictions that tried “high-quality” mask mandates also failed in spectacular fashion.

And that the only high-quality evidence review on masking confirmed no masks worked, even N95s, to prevent Covid transmission, as well as hearing that the CDC knew masks didn’t work anyway.
The website ends with a complete and thorough rebuke of the public health establishment and the Biden administration’s disastrous efforts to censor those who disagreed.
“Public health officials often mislead the American people through conflicting messaging, knee-jerk reactions, and a lack of transparency. Most egregiously, the federal government demonized alternative treatments and disfavored narratives, such as the lab-leak theory, in a shameful effort to coerce and control the American people’s health decisions.
When those efforts failed, the Biden Administration resorted to ‘outright censorship—coercing and colluding with the world’s largest social media companies to censor all COVID-19-related dissent.’”
About time these truths are acknowledged in a public, authoritative manner. Masks don’t work. Lockdowns don’t work. Fauci lied and helped cover up damning evidence.
If only this website had been available years ago.
Though, of course, knowing the media’s political beliefs, they’d have ignored it then, too.
Republished from the author’s Substack
-
Energy1 day ago
B.C. Residents File Competition Bureau Complaint Against David Suzuki Foundation for Use of False Imagery in Anti-Energy Campaigns
-
Alberta2 days ago
Alberta uncorks new rules for liquor and cannabis
-
COVID-191 day ago
Court compels RCMP and TD Bank to hand over records related to freezing of peaceful protestor’s bank accounts
-
Crime2 days ago
Project Sleeping Giant: Inside the Chinese Mercantile Machine Linking Beijing’s Underground Banks and the Sinaloa Cartel
-
C2C Journal22 hours ago
Canada Desperately Needs a Baby Bump
-
International1 day ago
Trump transportation secretary tells governors to remove ‘rainbow crosswalks’
-
Alberta1 day ago
Alberta Next: Alberta Pension Plan
-
Agriculture10 hours ago
Lacombe meat processor scores $1.2 million dollar provincial tax credit to help expansion